bayer
| 2:35PM 12/05/2011
Birth control drugs that were heavily promoted as having fewer side effects are now under scrutiny from the FDA in the wake of new research suggesting that they are more likely to cause blood clots than older drugs.
| 10:15AM 10/28/2010
German multinational corporation Bayer Healthcare has settled charges by three states that it exploited the fear of prostate cancer to market its One-A-Day men's multivitamins, despite the lack of any supporting evidence that the vitamins decreased the cancer risk.
Under the $3.3 million...
| 1:43PM 6/14/2010
Micromet shares traded some 3.3% higher on Monday after the small-cap biotech announced that its candidate drug blinatumomab led to remission in almost four-fifths of leukemia patients in a Phase II trial. It also said that a Phase I trial showed the drug induced durable remission in patients with non-Hodgkin lymphoma.
| 4:00PM 6/18/2009
Selenium for prostate health? We've heard that claim for Bayer Healthcare's One A Day Men's 50+ Advantage, which also cites ingredients lycopene, vitamin E and zinc as contributors to a happy prostate.
New research, however, has shown that supplementing the intake of selenium and Vitamin E will...